![](../COMMON/empty.gif)
![](../COMMON/picview.php?hostid=28501654640IMf4x1tH6sixg) | |
Published | : | | ![](../COMMON/empty.gif) | Books | : | Name:特定標的之新藥開發: 第九章 臨床前藥物動力學試驗 (2005) Authors:林君榮
| Posters & Speeches | : | Subjects:Enhancement of dissolution rate and oral bioavailability of lovastatin in red yeast rice products (2014) Speakers:Chia-Hao Chen, Jyh-Chin Yang, Yow-Shieng Uang, Chun-Jung Lin Address:5th FIP Pharmaceutical Sciences World Congress (PWSC), Melbourne, Australia
Subjects:The interaction between human PMAT and N-methyl-(R)SAL/1-benzyl-TIQ (2013) Speakers:Kuo-Chen Wu, Yi-Hsuan Peng, Ya-Hsuan Lu, Chun-Jung Lin Address:The 11th International Conference On Alzheimer’s & Parkinson’s Disease. Firenze, Italy
Subjects:Pharmacokinetic/pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter Pylori (2012) Speakers:Yu-Fan Yang, Jyh-Chin Yang, Yow-Shieng Uang, Chun-Jung Lin Address:World Conference on Pharmacometrics, Seoul, Korea
Subjects:The effects of Chinese red yeast rice on the activities of CYP450 enzymes and P-glycoprotein and the pharmacokinetic study of LipoCol Forte® in healthy volunteers. (2011) Speakers:Chia-Hao Chen, Jyh-Chin Yang, Yow-Shieng Uang, Shang-Ta Wang, Chun-Jung Lin Address:AAPS annual meeting at Walter E. Washington Convention Center, Washington, DC, USA
Subjects:The PKC-mediated down-regulation of P-glycoprotein expression under high glucose condition in MDCK II cells (2011) Speakers:Szu-Yu Yeh, Chung-Cheng Lin, Chun-Jung Lin Address:Bethesda AAPS (American Association of Pharmaceutical Scientists) Workshop, Bethesda North Marriott Conference Center, Bethesda, MD, USA.
Subjects:High Cumulative Eradication rate in the First-line and Rescue therapy for Helicobacter pylori infection by Repeated High dose dual therapy (2015) Speakers:Jyh-Chin Yang, Chun-Jung Lin, Jin-De Chen et al. Address:Digestive Disease Week (DDW), Washington, D.C. 20001, United States
Subjects:Effect of lipopolysaccharide on the expression of plasma membrane monoamine transporter (PMAT) at brain microvessels and the brain concentrations of 1-benzyl-1, 2, 3, 4-tetrahydroisoquinoline in C57BL/6 mice (2015) Speakers:Kuo-Chen Wu, Ya-Hsuan Lu, Chun-Jung Lin Address:7th Asian Association of School of Pharmacy (AASP) meeting, Taipei, Taiwan
Subjects:Increased P-glycoprotein expression in brain capillaries of Huntington’s disease transgenic mice and patients. (2016) Speakers:Kao YH, Chern Y, Yang HT, Chen HM, Lin CJ Address:11th Annual Huntington\'s disease therapeutics conference Palm Springs, CA, USA
Subjects:Genotypic testing is suboptimal to predict antibiotic resistance and therapeutic outcome for Helicobacter pylori eradication in clinical practice (2016) Speakers:Jyh-Chin Yang, Chun-Jung Lin, Huei-Mi Li et al. Address:Digestive Disease Week (DDW) San Diego, California, USA
Subjects:Changes in the pharmacokinetics of fluvastatin, atorvastatin, and simvastatin but not of rosuvastatin and pravastatin in collagen-induced arthritis rats (2017) Speakers:Chun-Han Lin, Ke-Wei Hsu, Chia-Hao Chen, Yow-Shieng Uang, Chun-Jung Lin Address:6th FIP Pharmaceutical Sciences World Congress (PSWC) Stockholm, Sweden
Subjects:Brain homeostasis of α-synuclein differs in mice with and without functional Nramp1 under PD-related pathological conditions (2018) Speakers:Kuo-Chen Wu, Chun-Jung Lin Address:International conference on Alzheimer’s disease & Dementia, Tokyo, Japan
Subjects:The role of equilibrative nucleoside transporter-2 in the modulation of neuroinflammation (2018) Speakers:Chih-Yu Lee, Kuo-Chen Wu, Yu-Han Kao, Chun-Jung Lin Address:2018 Society for Neurosciences annual meeting, San Diego, USA
Subjects:The role of equilibrative nucleoside transporter-2 on the amelioration of acute lipopolysaccharide-induced breakdown of the blood-brain barrier (2019) Speakers:Kuo-Chen Wu, Chun-Jung Lin Address:Brain & brain PET 2019 (Yokohama, Japan)
Subjects:Roles of equilibrative nucleoside transporter-2 in energy homeostasis in the striatum of mice (2022) Speakers:C.-J. HO1, C.-Y. CHEN1, K.-C. WU1, Y. CHERN2, C.-J. LIN Address:SfN (USA)
Subjects:Inhibition of equilibrative nucleoside transporter 1 (ENT1) inhibitor as a novel therapeutic treatment to rescue Alzheimer’s disease pathology and cognitive impairment (2022) Speakers:Ching-Wen Wu, Ching-Pang Chang, Chien-Yu Lin, Kuo-Chen Wu, Hsin-Hsien Yeh, Chun-Jung Lin, Yijuang Chern Address:CTAD (USA)
| Research Projects | : | Subject:The role of neurodegenerative dseases on the transport of nucleoside drugs across the blood-brain barrier Duration:2011-05 ~ 2014-04 Principal Investigator:Chun-Jung Lin
Subject:The investigation of the role of SLC11A1 on the degradation of alpha-synuclein and its implication to alpha-synuclein-induced neurotoxicity Duration:2016-08 ~ 2017-07 Principal Investigator:Chun-Jung Lin
Subject:Effects of rheumatoid arthritis on the expression of CYP450 enzymes and transporters and its implications to the pharmacokinetics of statins Duration:2015-08 ~ 2016-07 Principal Investigator:Chun-Jung Lin
Subject:Targeting brain adenosine homeostasis for the treatment of Huntington’s disease Duration:2015-01 ~ 2015-12 Principal Investigator:Chun-Jung Lin
Subject:The roles of neurons and astrocytes in the modulation of adenosine and adenine nucleotides in the brain of Huntington\\\'s disease Duration:2017-01 ~ 2017-12 Principal Investigator:Chun-Jung Lin
Subject:The implications of ENT2 in the modulation of neuroinflammation and disease progression in Huntington\\\'s disease Duration:2018-08 ~ 2021-07 Principal Investigator:Chun-Jung Lin
Subject:The effects of rheumatoid arthritis and the treatment of nonsteroidal anti-inflammatory drugs on the regulation of the blood-brain barrier and its implications to the transport of beta-amyloid Duration:2017-08 ~ 2020-07 Principal Investigator:Chun-Jung Lin
Subject:The investigation of the roles of equilibrative nucleoside transporters on pathological response and disease progression of ischemic stroke and ischemia-reperfusion injury Duration:2021-08 ~ 2024-07
Subject:Treatment of Alzheimer's disease by overcoming energy crisis Duration:2021-01 ~ 2024-12
Subject:The investigation of the roles of brain adenosine homeostasis on the pathogenesis and treatment of Parkinson's disease Duration:2020-08 ~ 2021-07 Principal Investigator:Chun-Jung Lin
|
|